Cargando…
Lymphocyte function in untreated Hodgkin's disease: an important predictor of prognosis.
One hundred and twenty seven consecutive and previously untreated patients with Hodgkin's disease (HD) (mean age 47 years) from the Stockholm area admitted to Radiumhemmet, Karolinska Hospital, were studied. The age-matched control group consisted of 167 healthy adults. Incorporation of [14C]-d...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1982
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010951/ https://www.ncbi.nlm.nih.gov/pubmed/6977367 |
_version_ | 1782136429968621568 |
---|---|
author | Wedelin, C. Björkholm, M. Holm, G. Ogenstad, S. Johansson, B. Mellstedt, H. |
author_facet | Wedelin, C. Björkholm, M. Holm, G. Ogenstad, S. Johansson, B. Mellstedt, H. |
author_sort | Wedelin, C. |
collection | PubMed |
description | One hundred and twenty seven consecutive and previously untreated patients with Hodgkin's disease (HD) (mean age 47 years) from the Stockholm area admitted to Radiumhemmet, Karolinska Hospital, were studied. The age-matched control group consisted of 167 healthy adults. Incorporation of [14C]-dT was measured on Day 1 in unstimulated monocyte-depleted lymphocyte cultures, and on Day 3 in cultures activated by PWM, ConA and PPD, T and B cells were enumerated by surface markers. The patients had significantly decreased relative and total T-cell counts, and the lymphocyte DNA synthesis induced by mitogens and PPD was severely impaired, whilst the spontaneous DNA synthesis was significantly greater than in controls. At follow-up (mean 4 years) 40 patients have died. Deceased patients showed greater spontaneous lymphocyte activation and less response to mitogen and antigen stimulation than the survivors. The 5-year survival of patients with severe lymphocyte impairment was 20%, compared to 80% for the remainder. The lymphocyte tests added prognostic information to that from clinical staging. Disregarding the lack of knowledge of the mechanisms underlying the lymphocyte impairment, we suggest that these relatively simple immunological tests should be included in the clinical evaluation of HD patients and would guide the choice of therapy. |
format | Text |
id | pubmed-2010951 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1982 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-20109512009-09-10 Lymphocyte function in untreated Hodgkin's disease: an important predictor of prognosis. Wedelin, C. Björkholm, M. Holm, G. Ogenstad, S. Johansson, B. Mellstedt, H. Br J Cancer Research Article One hundred and twenty seven consecutive and previously untreated patients with Hodgkin's disease (HD) (mean age 47 years) from the Stockholm area admitted to Radiumhemmet, Karolinska Hospital, were studied. The age-matched control group consisted of 167 healthy adults. Incorporation of [14C]-dT was measured on Day 1 in unstimulated monocyte-depleted lymphocyte cultures, and on Day 3 in cultures activated by PWM, ConA and PPD, T and B cells were enumerated by surface markers. The patients had significantly decreased relative and total T-cell counts, and the lymphocyte DNA synthesis induced by mitogens and PPD was severely impaired, whilst the spontaneous DNA synthesis was significantly greater than in controls. At follow-up (mean 4 years) 40 patients have died. Deceased patients showed greater spontaneous lymphocyte activation and less response to mitogen and antigen stimulation than the survivors. The 5-year survival of patients with severe lymphocyte impairment was 20%, compared to 80% for the remainder. The lymphocyte tests added prognostic information to that from clinical staging. Disregarding the lack of knowledge of the mechanisms underlying the lymphocyte impairment, we suggest that these relatively simple immunological tests should be included in the clinical evaluation of HD patients and would guide the choice of therapy. Nature Publishing Group 1982-01 /pmc/articles/PMC2010951/ /pubmed/6977367 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Wedelin, C. Björkholm, M. Holm, G. Ogenstad, S. Johansson, B. Mellstedt, H. Lymphocyte function in untreated Hodgkin's disease: an important predictor of prognosis. |
title | Lymphocyte function in untreated Hodgkin's disease: an important predictor of prognosis. |
title_full | Lymphocyte function in untreated Hodgkin's disease: an important predictor of prognosis. |
title_fullStr | Lymphocyte function in untreated Hodgkin's disease: an important predictor of prognosis. |
title_full_unstemmed | Lymphocyte function in untreated Hodgkin's disease: an important predictor of prognosis. |
title_short | Lymphocyte function in untreated Hodgkin's disease: an important predictor of prognosis. |
title_sort | lymphocyte function in untreated hodgkin's disease: an important predictor of prognosis. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010951/ https://www.ncbi.nlm.nih.gov/pubmed/6977367 |
work_keys_str_mv | AT wedelinc lymphocytefunctioninuntreatedhodgkinsdiseaseanimportantpredictorofprognosis AT bjorkholmm lymphocytefunctioninuntreatedhodgkinsdiseaseanimportantpredictorofprognosis AT holmg lymphocytefunctioninuntreatedhodgkinsdiseaseanimportantpredictorofprognosis AT ogenstads lymphocytefunctioninuntreatedhodgkinsdiseaseanimportantpredictorofprognosis AT johanssonb lymphocytefunctioninuntreatedhodgkinsdiseaseanimportantpredictorofprognosis AT mellstedth lymphocytefunctioninuntreatedhodgkinsdiseaseanimportantpredictorofprognosis |